Studies have shown that melatonin-treated P-exos have a significant effect on the treatment of inflammation after ischemia, which can reduce the pyrodeath of microglia and neurons by regulating the NF-κB signaling pathway, thus reducing the size of cerebral infarction [47]. The gene discussed is NFKB1; the disease is cerebral infarction.